Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in ENANTA PHARMACEUTICALS INC
FARALLON CAPITAL MANAGEMENT LLC holds 2.8M shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $43.7M as of 2025-Q4. The position was increased (++30.6% shares). ENTA represents 0.2% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$43.7M
Current Shares
2.8M
Total Value Change
+$16.5M
Total Shares Change
+677,262
Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.8M |
+30.6% |
| $43.7M |
| 0.2% |
| $15.90 |
44 |
| 2025-Q3 | Unchanged | 2.1M | 0.0% | $25.4M | 0.1% | $15.16 | 0 |
| 2025-Q2 | Unchanged | 2.1M | 0.0% | $16M | 0.1% | $7.50 | 0 |
| 2025-Q1 | Increased | 2.1M | +0.7% | $11.7M | 0.1% | $5.71 | 28 |
| 2024-Q4 | Unchanged | 2.1M | 0.0% | $12.1M | 0.1% | $5.85 | 0 |
| 2024-Q3 | Increased | 2.1M | +0.6% | $21.8M | 0.1% | $10.05 | 34 |
| 2024-Q2 | Unchanged | 2.1M | 0.0% | $27.2M | 0.1% | $12.97 | 0 |